Cellectar Biosciences INC NEW (CLRB) is a publicly traded Healthcare sector company. As of May 21, 2026, CLRB trades at $3.10 with a market cap of $25.09M and a P/E ratio of -0.38. CLRB moved +3.43% today. Year to date, CLRB is -5.37%; over the trailing twelve months it is -59.97%. Its 52-week range spans $2.43 to $67.50. Analyst consensus is strong buy with an average price target of $10.33. Rallies surfaces CLRB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What are CLRB's key financials?
CLRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLRB recently traded at $3.10. Market cap is $25.09M. P/E ratio is -0.38. Revenue is $0.
CLRB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLRB recently traded at $3.10. Market cap is $25.09M. P/E ratio is -0.38. Revenue is $0.
Is CLRB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLRB. It does not provide personalized investment advice.
